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Abstract
Background: The present study sought to further investigate the in vitro and in vivo anticancer effects of a representative
omega-3 fatty acid, docosahexaenoic acid (DHA), with a focus on assessing the induction of oxidative stress and apoptosis
as an important mechanism for its anticancer actions.
Methodology/Principal Findings: In vitro studies showed that DHA strongly reduces the viability and DNA synthesis of
MCF-7 human breast cancer cells in culture, and also promotes cell death via apoptosis. Mechanistically, accumulation of
reactive oxygen species and activation of caspase 8 contribute critically to the induction of apoptotic cell death. Co-
presence of antioxidants or selective inhibition or knockdown of caspase 8 each effectively abrogates the cytotoxic effect of
DHA. Using athymic nude mice as an in vivo model, we found that feeding animals the 5% fish oil-supplemented diet for 6
weeks significantly reduces the growth of MCF-7 human breast cancer cells in vivo through inhibition of cancer cell
proliferation as well as promotion of cell death. Using 3-nitrotyrosine as a parameter, we confirmed that the fish oil-
supplemented diet significantly increases oxidative stress in tumor cells in vivo. Analysis of fatty acid content in plasma and
tissues showed that feeding animals a 5% fish oil diet increases the levels of DHA and eicosapentaenoic acid in both normal
and tumorous mammary tissues by 329% and 300%, respectively.
Conclusions/Significance: DHA can strongly induce apoptosis in human MCF-7 breast cancer cells both in vitro and in vivo.
The induction of apoptosis in these cells is selectively mediated via caspase 8 activation. These observations call for further
studies to assess the effectiveness of fish oil as a dietary supplement in the prevention and treatment of human breast
cancer.
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Introduction
Omega-3 fatty acids (FAs
") are long-chain polyunsaturated FAs.
The principal dietary source of eicosapentaenoic acid (EPA, 20:5n-
3) and docosahexaenoic acid (DHA, 22:6n-3) is from oily cold-
water fish [1,2]. Epidemiological studies have suggested that an
increased fish oil intake is associated with a reduced breast cancer
incidence in humans [3,4]. Consistent with this epidemiological
observation, laboratory studies have also shown that omega-3 FAs
can suppress the formation and growth of breast cancer in animal
models [5–8].
A number of mechanisms have been proposed for the
anticancer actions of omega-3 FAs, including suppression of
neoplastic transformation, inhibition of cell proliferation, enhance-
ment of apoptosis, and antiangiogenicity [1,9]. Most of these
mechanisms have been directly or indirectly linked to their
inhibition of the production of eicosanoids from omega-6 FAs
[7,9,10]. In addition, it has also been suggested that increased lipid
peroxidation may contribute to the anticancer actions of omega-3
FAs. Earlier studies have shown that accumulation of polyunsat-
urated FAs would lead to increased formation of lipid hydroper-
oxides as well as other degradation products that may be
deleterious to cells [11–14]. Moreover, it was observed that the
presence of antioxidants diminished their anticancer activity in
cultured cancer cells, whereas the presence of prooxidants
enhanced their anticancer activity [15,16].
Using MCF-7 human breast cancer cells as an in vitro model,
early studies have shown that omega-3 FAs not only inhibit their
growth, but they also induce differentiation and apoptosis [17–19].
In the present study, we sought to further investigate the
anticancer efficacy of omega-3 FAs, DHA in particular, on the
growth of MCF-7 human breast cancer cells in vitro and in vivo (as
xenografts in athymic nude mice), with a focus on assessing the
induction of oxidative stress and apoptosis as a crucial mechanistic
element for their anticancer activity. In addition, we have also
determined the levels of omega-3 FAs in normal and tumorous
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We believe a better understanding of the mechanism of the
anticancer actions of omega-3 FAs would aid in the development
of new cancer therapeutic strategies involving the use of fish oil as
a dietary supplement.
Materials and Methods
Chemicals and reagents
DHA, EPA, linoleic acid (LA, 18:2n-6), arachidonic acid (AA,
20:4n-6), boron trifluoride, Eagle’s modified minimum essential
medium (EMEM, phenol red-free), and fetal bovine serum (FBS)
were obtained from Sigma Chemical Co. (St. Louis, MO). Iscove’s
Modified Dubecco’s Medium (IMEM) and an antibiotics solution
containing 10,000 U/mL penicillin and 10 mg/mL streptomycin
were obtained from Invitrogen (Carlsbad, CA). The trypsin-
EDTA mixture (containing 0.25% trypsin and 0.02% EDTA) was
obtained from Lonza Walkersville (Walkersville, MD). Caspase
inhibitors (zVAD-FMK, IETD-FMK, LEHD-FMK, and zVEID-
FMK) were obtained from EMD Chemicals Inc. (Gibbstown, NJ).
Scramble siRNA and caspase 8-specific siRNA were obtained
from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). All other
reagents used in this study were obtained from standard suppliers
and were of analytical grade or higher.
In vitro experiments
Cell culture. MCF-7, MDA-MB-231 and MDA-MB-435s
cell lines were obtained from the American Type Culture
Collection (ATCC, Rockville, MD). MCF-7 cells were
maintained in EMEM supplemented with 10% (v/v) fetal bovine
serum, and MDA-MB-231 and MDA-MB-435s cells were
maintained in IMEM (with 10% fetal bovine serum). These cells
were incubated at 37uC under 5% CO2, and usually sub-cultured
once every 3 days.
Assay of cell viability and DNA synthesis. For
determining the rate of cell viability, the MTT [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay was
used. MCF-7, MDA-MB-231 and MDA-MB-435s cells were
seeded in 96-well plates at a density of 2,000 cells per well. The
stock solution of DHA or EPA (100 mM in 200-proof ethanol) was
diluted in ethanol first and then in the culture medium
immediately before addition into each well at the desired final
concentrations, and the treatment usually lasted for 3 days unless
noted otherwise. For MTT assay, 20 mL MTT (at 5 mg/mL) was
added to each well at a final concentration of 500 mg/mL, the
mixture was further incubated for 1 h, and the liquid in the wells
was removed thereafter. Fifty microliters of dimethyl sulfoxide
were then added to each well, and the absorbance was read with a
UV max microplate reader (Molecular Device, Palo Alto, CA) at
560 nm. The relative cell viability was expressed as a percentage of
the control that was not treated with DHA or EPA.
The thymidine incorporation assay was used for determining
the rate of DNA synthesis. Cells (in 96 well plates) were incubated
in the presence of [methyl-
3H]thymidine (5 nM, 1 mCi per well,
PerkinElmer, Boston, MA) for 12 h. Then the cells were harvested
onto glass fiber filters, and the incorporated radioactivity was
counted using a b-scintillation counter (MicroBeta Trilux,
PerkinElmer Life Sciences).
Flow cytometric analyses of cell death. The annexin-V
and PI double staining method was used. MCF-7 cells were
harvested with trypsin-EDTA and then stained with the Annexin
V-FITC Apoptosis Detection Kit (BD Biosciences, San Jose, CA)
according to manufacturer’s protocols. Then the cells were
subjected to flow cytometric analysis with a flow cytometer
(model BD LSR II, BD Bioscience, San Jose, CA). In this assay,
annexin-V would detect the translocation of phosphatidylserine
from the inner leaflets to the outer leaflets of the plasma
membrane, which is a key feature of apoptotic cells, whereas PI
would detect necrotic cells with permeabilized plasma membrane.
TUNEL staining. Apoptotic DNA degradation was stained
using the terminal deoxynucleotidyl transferase (TdT)-mediated
dUDP-biotin nick end labeling (TUNEL) method. In this study,
the ApopTagH Plus Peroxidase In Situ Apoptosis Detection Kit
(Chemicon International, Temecula, CA) was used for this
purpose.
Intracellular ROS measurement. For determination of the
intracellular accumulation of ROS, the 29,79-dichlorofluorescein
diacetate (H2-DCF-DA) method was used. After treatment of
cultured cells (in 6-well plates) with DHA for the length of time as
indicated, H2-DCF-DA (at a final concentration of 2 mM in the
whole medium) was added to each well. After incubation for
20 min at 37uC, cells were washed with PBS twice with 20 min
each time. Intracellular ROS accumulation was observed and
photographed using a fluorescence microscope (AXIO, Carl Zeiss
Corporation, Germany).
3-Nitrotyrosine level in cultured cells was determined using the
immunocytochemical staining method. The specific antibody for
3-nitrotyrosine (1:1000 dilution) was obtained from Cell Signaling
Technology (Danvers, MA). Slides were counter-stained for nuclei
with DAPI.
Transfection of siRNA and Western blotting anal-
ysis. siRNA was transfected into the cells using Lipofectamine
2000 (invitrogen) according to manufacturers’ instructions. After
24 h, cells were harvested and washed with PBS, and then they
were suspended in 100 ml of the lysis buffer (20 mM Tris-HCl,
150 mM NaCl, 1 mM EDTA, 1% Triton X-100, and a protease
inhibitor cocktail, pH 7.5). The amount of proteins was
determined using the Bio-Rad protein assay (Bio-Rad, Hercules,
CA). An equal amount of proteins was loaded in each lane,
separated by 12% SDS-polyacrylamide gel electrophoresis (SDS-
PAGE), and electrically transferred to a polyvinylidene difluoride
membrane (Bio-Rad). After blocking the membrane using 5%
skim milk, target proteins were immunodetected using specific
antibodies. All primary antibodies were obtained from Cell
Signaling Technology (Beverly, MA). Thereafter, the horseradish
peroxidase (HRP)-conjugated anti-rabbit IgG was applied as a
secondary antibody and the positive bands were detected using
Amersham ECL plus Western Blotting Detection Reagents (GE
Health care, Piscataway, NJ).
Caspase 8 activity assay. MCF-7 cells were plated in 6-well
plates and treated with DHA for different time periods. Then the
cells were harvested and caspase 8 activity was measured by using
a colorimetric ApoAlert Caspase-8 Assay Kit (colormetric) from
Clonetech Laboratories, Inc. (Mountain View, CA) according to
manufacturer’s instructions.
In vivo experiments
Experimental design. All procedures involving the use of
live animals as described in this study were approved by the
Institutional Animal Care and Use Committee of the University of
Kansas Medical Center, and the investigators strictly followed the
NIH guidelines for humane treatment of animals. Female athymic
nu/nu mice, 4–5 weeks of age, were obtained from Harlan
Laboratories (Indianapolis, IN). They were exposed to a 12-h
light/12-h dark cycle, and had free access to a Harlan Teklad
Rodent Diet 8604 (Harlan Teklad, Madison, WI) and water. Mice
were housed under aseptic conditions (positive air pressure in a
designated mouse room, with microisolator tops) and all mouse
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After approximately one week of acclimatization after arrival,
MCF-7 or MDA-MB-435s cells (5610
6 cells in 100 mL PBS) were
s.c. injected into the right and left flanks of the animals. They were
fed Harlan Teklad Rodent Diet 8604 while the injected cancer
cells were allowed to grow for 2 weeks into tumors in the host
animals before the start of feeding the experimental diets. The
tumor-bearing mice were randomized into the following four
groups (5 animals per group): Group 1 (MCF-7 cell xenograft),
Group 2 (MCF-7 cell xenograft+fish oil diet), Group 3 (MDA-MB-
435s cell xenograft), and Group 4 (MDA-MB-435s cell
xenografts+fish oil diet). One of the groups of mice was treated
with the control diet (AIN-76A diet containing 5% corn oil,
Harlan Teklad., Madison, WI) and all other groups of animals
were fed the fish oil-supplemented diet (AIN-76A diet containing
5% menhaden oil, prepared by Harlan Teklad, Madison, WI).
These diets contained similar quantities of carbohydrates, protein,
lipids, vitamins, and minerals (summarized in Table 1), and the
only difference is the types of lipids (i.e., corn oil vs. fish oil). Both
diets were stored in sealed containers at 220uC to reduce
spontaneous lipid peroxidation.
Tumor and body weight measurements. The maximum
and minimum diameters of the tumors (using a sliding caliper),
body weight and amount of food intake were measured twice a
week. Assuming that tumors formed in the animals were spherical,
their volume was calculated using the formula [p/66d
3], where d
is the mean diameter [20].
Analysis of plasma and tissue FA levels. Plasma and
tissues (breast, uterus, skin, and tumor) were harvested from each
animal, snap-frozen in liquid nitrogen, and stored in a 280uC
freezer until analysis. The measurement of linoleic acid,
arachidonic acid, EPA and DHA in plasma and tissues were
conducted as described earlier [21–23]. Briefly, total lipids from
plasma were extracted using the chloroform:methanol mixture
(2:1, v/v), dried under a stream of nitrogen, and transmethylated
using boron trifluoride in methanol (14 g/L). FA methyl esters
were extracted from the mixture with pentane containing 0.05%
butylated hydroxytoluene. One microliter of transmethylated
sample was injected into the Agilent gas chromatography 6890N
linked with the 5975B mass spectrometer. Capillary column HP5-
MS (30 m60.25 mm, 0.25 mm film thickness) was used for
separation and helium as the carrier gas. The column oven
temperature was set at 120uC, ramped to 250uCa t3 uC/min, then
ramped to 300uCa t1 0 uC/min, and held at 300uC for 5 min.
Morphological and histopathological analyses. Tumor
samples from each animal were removed and fixed in 10%
buffered formalin phosphate (Fisher Scientific, Pittsburgh, PA),
cryosectioned to 5-mm thickness, and stained with hematoxylin
and eosin (H/E).
For immunohistochemical staining of the proliferating cell
nuclear antigen (PCNA) and 3-nitrotyrosine, antigen retrieval
procedure was performed by placing the slides in 10 mM citrate
buffer (pH 3.0), heating in a microwave oven for 20 min and then
allowing the slides to cool to room temperature for 20 min. Slides
were rinsed once with PBS, and endogenous peroxidase activity
was blocked by incubating the samples for 30 min with 3% H2O2
in PBS, followed by rinsing 3 times with PBS. Nonspecific binding
was blocked by incubating the slides for 30 min in 2% normal goat
serum (Vector Laboratories, Burlingame, CA) in 1% Triton X-100
containing PBS, followed by incubation with the specific
antibodies against PCNA (1:500 dilution, Abcam Inc., Cambridge,
MA) and 3-nitrotyrosine (1:100 dilution, Cell Signaling Technol-
ogy Inc., Danvers, MA) in the blocking solution as described
above. Then, slides were incubated with biotinylated goat anti-
rabbit IgG (dilution, 1:500, Vector Laboratories) in the blocking
solution as described above. Next, the slides were incubated for
2 h with the avidin-biotin peroxidase complex (Vector Laborato-
ries) according to the manufacturer’s instructions, followed by
5 min incubation with a DAB substrate kit (Vector Laboratories).
Counterstaining was performed using Mayer’s hematoxylin.
Negative controls lacking the primary antibody were used for
each staining.
Apoptotic DNA degradation in tumor tissue was stained by the
TUNEL method using the ApopTagH Plus Peroxidase In Situ
Apoptosis Detection Kit (Chemicon International).
Data analysis
The quantitative data were expressed as means 6 S.D.. Statis-
tical significance was determined using the analysis of variance
(ANOVA) followed by a multiple comparison test with a
Bonferroni adjustment. P values of ,0.05 were considered
statistically significant.
Results
DHA and EPA inhibit the growth of human breast cancer
cells in vitro
We first determined the effect of DHA and EPA on the viability
(MTT assay) of cultured MCF-7, MDA-MB-231 and MDA-MB-
435s cells. As shown in Fig. 1A, treatment with DHA and EPA for
3 days inhibited the viability of MCF-7 cells in a concentration-
dependent manner, with IC50 values of 20.2 and 57.4 mM,
respectively. Compared to MCF-7 cells, MDA-MB-435s and
MDA-MB-231 cells were less sensitive to DHA and EPA, with
IC50 values of approximately 70–100 mM and .200 mM,
respectively. The time-dependent reduction of cell viability and
inhibition of DNA synthesis in cultured MCF-7 cells following
treatment with 25 mM DHA were compared by using the MTT
assay and [
3H]thymidine incorporation assay, respectively. As
shown in Fig. 1B, cell viability (MTT assay) started to decrease at
48 h after DHA treatment, and approximately 80% of the cells
lost viability at 72 h. In comparison,
3H-thymidine incorporation
assay showed that when DNA synthesis was inhibited by 50% at
48 h, over 90% of cell viability was still retained, suggesting that
inhibition of DNA synthesis might precede the reduction in cell
viability.
Table 1. Composition of the experimental diets used in this
study.
Control diet Fish oil diet
Casein (g/Kg) 200.0 200.0
DL-Methionine (g/Kg) 3.0 3.0
Sucrose (g/Kg) 500.0 500.0
Corn starch (g/Kg) 150.0 150.0
Corn oil (g/Kg) 50.0
1 -
Fish oil (g/Kg) - 50.0
1
Cellulose (g/Kg) 50.0 50.0
Mineral mix, AIN-76 (170915) (g/Kg) 35.0 35.0
Vitamin mix, AIN-76A (40077) (g/Kg) 10.0 10.0
Choline bitartrate (g/Kg) 2.0 2.0
Ethoxyquin, antioxidant (g/Kg) 0.01 0.01
1Differs in diet.
doi:10.1371/journal.pone.0010296.t001
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induced cell death, the annexin V/PI double staining method was
used. With this method, cells stained single positive for PI were
considered mostly necrotic cells, and cells stained single-positive for
annexin-V were considered mostly early apoptotic cells, but cells that
were stained double-positive could be either necrotic or apoptotic
cells [24–26]. As shown in Fig. 1C, there was no increase in the PI
single positive cells (reflecting mostly necrotic cells) after treatment of
Figure 1. DHA and EPA inhibit MCF-7 cell growth in a concentration-dependent manner. (A) Cell viability (MTT assay) of MCF-7 cells,
MDA-MB-231 and MDA-MB-435s cells treated with DHA or EPA at indicated concentrations for 72 h. Each value is the mean 6 S.E. (n=6). Note that
for some of the data points, the error bars are smaller than the diameter of the symbols. (B) MTT and thymidine incorporation assays for MCF-7 cells
treated with 25 mM DHA for the indicated length of time. Each value is the mean 6 S.E. (n=6 for both assays). (C) Annexin V/PI staining of MCF-7 cells
treated with 15 mM and 25 mM DHA for the indicated length of time. The percentage of cells in each of the four quadrants was shown inside of each
area. (D) TUNEL staining of MCF-7 cells treated with 25 mM DHA for the indicated length of time. The dark brown cells were positively-stained cells.
(E) Quantification of TUNEL-positive cells as percentage of total cells. Each value is the mean 6 S.D. (n=3).
doi:10.1371/journal.pone.0010296.g001
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DHA-induced cell viability change of cultured MCF-7 cells. Cells were treated with DHA in the presence of different concentrations of the caspase
inhibitor IETD-FMK (for caspase 8), LEHD-FMK (for caspase 9), zVAD-FMK (for caspases 1, 3, 4, 7), or zVEID-FMK (for caspase 6) for 72 h. Each value is
the mean 6 S.E. (n=6). (B) Pro-caspase 8 protein expression level (Western blot analysis) in MCF-7 cells after transfection with scramble or caspase 8-
specific siRNA (without DHA treatment). (C) The effect of caspase 8 knockdown on 25 mM DHA-induced death of cultured MCF-7 cells. Cells were first
transfected with scramble or caspase 8-specific siRNA, and then they were treated with 25 mM DHA for additional 72 h. Each value is the mean 6 S.E.
(n=6). (D) Time-dependent increase of caspase 8 activity in MCF-7 cells treated with 25 mM DHA for 24, 48, or 72 h. Each value is the mean 6 S.E.
(n=3).
doi:10.1371/journal.pone.0010296.g002
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Instead, the annxin V single positive cells (reflecting mostly apoptotic
cells) were increased following DHA treatment in a dose- and time-
dependent manner. As a validation of the flow cytometry data on the
DHA-induced apoptotic cell death, we also quantified the TUNEL-
positive cells following DHA treatment of MCF-7 cells. As expected,
the TUNEL-positivecellswere increased after treatment with 25 mM
DHA in a time-dependent manner (Fig. 1D, 1E). The percentage of
TUNEL-positive cells correlated closely with the annexin V-positive
cells in Fig. 1C. Taken together, the data from both annexin V-PI
double staining and TUNEL assay consistently showed that DHA
predominantly induced apoptosis in cultured MCF-7 cells.
DHA-induced death in MCF-7 cells is mediated via
caspase activation
To determine whether activation of caspases was involved in
DHA-induced death in cultured MCF-7 cells, pharmacological
inhibitors of caspases were employed to probe whether they could
Figure 3. DHA induces ROS accumulation in MCF-7 cells. (A) Cell viability (MTT assay) of MCF-7 cells treated with different concentrations of a-
tocoperol,ascorbic acid,orN-acetylcysteine(NAC)andDHA.Eachvalueis themean 6S.E.(n=6). (B)ROSaccumulationmeasuredbyH2-DCF-DAstainingof
MCF-7 cells treatedwith 25 mMDHAortogether with1 mMa-tocoperolfor indicatedtimeperiods.Thepicturesweretaken undera fluorescent microscope
atthe1006magnification. (C)3-NitrotyrosinestainingofMCF-7cellstreatedwith25 mMDHAortogetherwith1 mMa-tocoperolforindicatedtimeperiods.
The pictures were taken under a fluorescent microscope at the 4006magnification. Each value is the mean 6 S.E. (n=3).
doi:10.1371/journal.pone.0010296.g003
DHA Induces Apoptosis in MCF-7
PLoS ONE | www.plosone.org 6 April 2010 | Volume 5 | Issue 4 | e10296Figure 4. Fish oil-supplemented diet inhibits the growth of MCF-7 cancer cell xenografts in athymic nude mice. The changes in body
weight (A), food intake amount (B) andtumor growth (C). Themacroscopic pictures of tumor (C) and morphological and histopathological analyses (D)
were assessed at the end of experiments. Nude mice were maintained on control or fish oil diet for 10 weeks after subcutaneous implantation of MCF-7
cells (5610
6 cells in 100 mL PBS). Both maximum and minimum diameters of the tumors, body weight and food intake amounts were measured twice a
week using slide caliper. Tumor volume was calculated assuming the tumor to be spherical using the formula [p/66d
3], where d is the mean diameter.
doi:10.1371/journal.pone.0010296.g004
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either caspase 8 or 9 was present, each of them strongly protected,
in a concentration-dependent manner the death induced by
25 mM DHA. The protective effect of the caspase 8 inhibitor
(IETD-FMK) was stronger than that of the caspase 9 inhibitor
(LEHD-FMK). For instance, the caspase 8 inhibitor at 5 mM
concentration completely abrogated DHA-induced loss of cell
viability in MCF-7 cells whereas the caspase 9 inhibitor restored
approximately 80% of cell viability. When the pan-caspase
inhibitor zVAD-FMK (an inhibititor of caspases 1, 3, 4 and 7),
or the caspase 6 inhibitor (zVEID-FMK) was present, a weaker
protection against DHA-induced cell death was observed (Fig. 2A).
To confirm the crucial role of caspase 8 in mediating DHA-
induced death in MCF-7 cells, we selectively knocked down its
expression in these cells using the caspase 8-specific siRNA.
Western blotting of caspase 8 confirmed that procaspase 8
expression in caspase 8 siRNA-transfected cells was markedly
decreased (Fig. 2B). As expected, knockdown of caspase 8 almost
completely abolished the apoptotic effect of DHA (Fig. 2C). To
confirm that DHA treatment results in activation of caspase 8, we
Figure 5. Fish oil-supplemented diet only slightly inhibits the growth of MDA-MB-435s cancer cell xenografts in athymic nude mice.
The changes in body weight (A), food intake amount (B) and tumor growth (C). Nude mice were maintained on control or fish oil diet for 6 weeks
after subcutaneous implantation of MDA-MB-435s cells (5610
6 cells in 100 mL PBS). Both maximum and minimum diameters of the tumors, body
weight and food intake amounts were measured twice a week using slide caliper. Tumor volume was calculated assuming the tumor to be spherical
using the following formula: volume=p/66d
3, where d is the mean diameter. Each value is the mean 6 S.D. (n=5).
doi:10.1371/journal.pone.0010296.g005
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Fig. 2D, caspase 8 activity was increased up to 5-fold after DHA
treatment at 72 h.
Taken together, these data demonstrated that caspase 8 plays a
critical role in mediating DHA-induced apoptotic cell death. The
observation that caspase 8 inhibition can completely block DHA-
induced cell death, in turn, provides support for the suggestion
that apoptosis is the predominant form of cell death induced by
DHA.
DHA induces ROS formation in MCF-7 cells
As shown in Fig. 3A (left panel), the antioxidants a-
tocopherol (vitamin E), ascorbic acid (vitamin C), and N-acetyl
cysteine (NAC) each protected MCF-7 cells against DHA-induced
death. a-Tocopherol was much more potent and efficacious than
ascorbic acid and NAC in protecting MCF-7 cells against DHA-
induced death (Fig. 3A, right panel). Using the H2-DCF-DA
staining, intracellular ROS accumulation was readily detected in
MCF-7 cells at 24 and 72 h following DHA treatment (as shown
by the green fluorescence in Fig. 3B). Co-treatment of cells with
1 mM a-tocopherol completely abrogated ROS accumulation
induced by 25 mM DHA, which supported the suggestion that
DHA-induced apoptosis was initiated by ROS accumulation. As
shown in Fig. 3C, 3-nitrotyrosine-positive cells were detected in
DHA-treated cells at 24 to 72 h, indicating that ROS and reactive
nitrogen species generated following DHA treatment caused
oxidative protein modifications in these cells. In comparison, cells
co-treated with a-tocopherol and DHA had no appreciable 3-
nitrotyrosine staining.
Fish oil-supplemented diet suppresses the growth of
MCF-7 human breast cancer cells in vivo
To further assess the anticancer efficacy of omega-3 FAs in vivo,
we used the cancer xenograft model in athymic nude mice. The
animals were injected s.c. into their right and left flanks MCF-7
human breast cancer cells (at 5610
6 cells in 100 mL PBS), and two
weeks later they were started to be fed a diet supplemented with
5% fish oil for 6 weeks. The average animal body weight was
23.5 g at the beginning of the fish oil diet treatment, and no
significant differences in the body weight were seen among
different treatment groups at the end of the experiment (Fig. 4A).
Also, the amount of food intake between the control and fish oil
diet groups was not significantly different throughout the
experiment (Fig. 4B). However, significantly larger tumor size
was observed in mice receiving the control diet (Fig. 4C), whereas
in mice treated with the fish oil-supplemented diet their tumor size
was basically not increased over the 6-week period (Fig. 4C).
Histological examination (H/E staining) of dissected tumor
sections showed that the tumor cell density was reduced in fish oil
diet-fed mice compared to the control diet group (Fig. 4D).
PCNA-labeling indices of tumors from mice treated with the
control diet were significantly higher than tumors from mice on
the fish oil diet, suggesting that there was a decrease of cancer cell
proliferation in the fish oil diet group. While the apoptotic indices
(TUNEL assay) in tumor tissue of control diet-fed animals were
mostly negative, the indices were markedly increased in animals
fed a fish oil-supplemented diet.
The cellular levels of 3-nitrotyrosine, a commonly-used marker
for protein nitration and cellular oxidative stress, were also
determined in tumor xenografts as a parameter for the
intracellular ROS levels. We found that the 3-nitrotyrosine level
was significantly elevated in tumor tissues from fish oil diet-fed
animals compared to control diet-fed animals (Fig. 4D).
Using the same tumor cell xenograft model, we also
determined the effect of fish oil on the growth of MDA-MB-
435s cells in nude mice for 10 weeks. As shown in Fig. 5C,t h e
tumor volume in animals fed a fish oil-supplemented diet was
only slightly smaller than that of the control diet group (but no
statistical significance). Similar to what was observed with the
MCF-7 cell xenograft experiment, animal body weight and food
intake between the control and fish oil diet groups were not
significantly different throughout the experiment (Fig. 5A, 5B).
The lack of a significant anticancer effect of the fish oil diet in
MDA-MB-435s tumor xenografts was consistent with the
markedly weaker effect seen in vitro with this human cancer cell
line. These data suggest that there was a cancer cell type-
dependent sensitivity toward omega-3 FAs.
Concentrations of FAs in diet, plasma and tissues
The concentrations of linoleic acid, arachidonic acid, EPA and
DHA in two different diets are shown in Fig. 6A. The control diet
mainly consisted of linoleic acid (at 3.760.4 mg/100 mg diet),
with negligible amount of arachidonic acid. In comparison, the
fish oil-supplemented diet contained EPA and DHA at 0.760.1
and 0.560.0 mg/100 mg diet, respectively, whereas the levels of
linoleic acid (LA) and arachidonic acid (AA) were below the
detection limit.
The plasma levels of essential FAs were markedly changed
following the 6-week feeding of the fish oil diet. While the omega-6
FA (linoleic acid and arachidonic acid) concentrations were higher
than the omega-3 FAs (EPA and DHA) in the control diet group, it
was reversed in the fish oil diet group (Fig. 6B). The animals fed
the fish oil diet had significantly increased plasma levels of DHA
and EPA by 2.5- and 11.3-fold, respectively, over those of the
control group. Because EPA and DHA were basically undetectable
in the control diet, their detection in the plasma of control diet-fed
animals suggests that small amount of EPA and DHA can be
biosynthesized in the body.
As shown in Fig. 6C, the amount of linoleic acid in the
mammary tissue was highest among the tissues tested. However,
the amount of linoleic acids in mammary, uterus and skin tissues
were reduced to 5, 39 and 37% of the baseline levels, respectively,
after feeding the fish oil diet (Fig. 6C). The tissue levels
of arachidonic acid in the normal breast, uterus, skin and
tumor tissues were 131.367.9, 145.668.0, 50.166.4 and
95.1623.3 mg/g wet tissue, respectively, but they were markedly
reduced in the fish oil diet group (Fig. 6D). The amount of
linoleic acid and arachidonic acid in tumor tissues was not
significantly changed by feeding the 5% fish oil diet (Fig. 6C,
6D). In the cases of omega-3 FAs, the levels of EPA and DHA in
the tissues of control animals were less than 200 mg/g wet tissue,
but they were significantly increased in all tissues after feeding 5%
fish oil diet (Fig. 6E, 6F). Importantly, the change in ratio of
omega-6 FAs (linoleic acid and arachidonic acid) to omega-3 FAs
(EPA and DHA) in mammary tissue before and after fish oil diet
Figure 6. Omega-3 fatty acid levels in diets, plasma and tissues. Concentrations of FAs in food (A) and plasma (B). Comparison of the
concentrations of LA (C), AA (D), EPA (E) and DHA (F) in various tissues. Nude mice were maintained on control or fish oil diet for 6 weeks after the
subcutaneous implantation of MCF-7 cells (5610
6 cells in 100 mL PBS). Each value is the mean 6 S.D. (n=5). * P,0.05 vs. the control diet group.
doi:10.1371/journal.pone.0010296.g006
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induction of apoptotic cell death. When antioxidants are co-present, they can effectively protect cells from undergoing apoptosis by suppressing ROS
formation. In comparison, the presence of inhibitors for various caspases or the selective knockdown of caspase 8 each shows a strong protection of
cells from DHA-induced apoptosis.
doi:10.1371/journal.pone.0010296.g007
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tested in this study.
Discussion
The results of our present study showed that DHA, an omega-3
FA, has a strong anticancer activity in cultured MCF-7 human
breast cancer cells through a combination of multiple actions,
including inhibition of DNA synthesis, suppression of cell viability,
and induction of apoptotic cell death. The strong in vitro anticancer
effect was also observed in vivo in the athymic nude mouse model.
These data confirmed and extended earlier observations
[17–19,27–29] on the anticancer effect of omega-3 FAs.
Mechanistically, the cell death induced by DHA is largely
mediated through increased production of ROS in cancer cells,
which subsequently results in apoptotic cell death. The crucial role
of ROS in DHA-induced death of MCF-7 cells is supported by the
following lines of observations made in the present study: First,
there was an increase in the intracellular ROS accumulation and
protein nitration in MCF-7 cells following treatment with DHA
(Fig. 3B, 3C). Second, the cytotoxicity induced by DHA in MCF-
7 cells was effectively protected by the co-presence of antioxidants
(Fig. 3A). Third, based on the cellular levels of 3-nitrotyrosine as a
marker for protein nitration and cellular oxidative stress, we also
demonstrated that there was a marked increase in 3-nitrotyrosine
levels in tumor tissues in the fish oil diet-fed animals compared to
the control diet-fed animals (Fig. 4D). This in vivo observation
agreed well with the in vitro data showing that there was a marked
increase in the oxidative stress in cells treated with DHA. Taken
together, these data suggest that DHA-induced cell death is largely
mediated through the formation of intracellular ROS. The
correlation between the in vitro and in vivo observations adds
weight to this mechanistic explanation.
It was reported earlier that while omega-3 FAs could selectively
inhibit tumor cell proliferation, they were significantly less
cytotoxic in normal cells [30,31]. The results of our present study
showed that the anticancer effect of DHA and EPA in different
human cancer cell lines (such as MCF-7, MDA-MB-231 and
MDA-MB-435s) was also markedly different (Fig. 1A). It was
suggested earlier that the levels of superoxide dismutase 1
expression plays an important role in determining the sensitivity
of different tumor cells to the cytotoxic effects of DHA [32]. This
suggestion appears to be in line with observations that increased
oxidative stress contributes importantly to the anticancer actions of
DHA.
A number of earlier studies have suggested that the anticancer
property of DHA is attributable to its ability to induce apoptosis
[17,19,27–29]. It was also reported that treatment of HL-60 cells
with EPA results in caspases 3, 6, 8 and 9 activation, Bid cleavage,
and cytochorme c release [33]. The results of our present study
using annexin-V/PI double staining and TUNEL assay confirmed
that DHA can induce apoptosis both in vitro and in vivo (Fig. 1C,
1D, 1E and 4D). In addition, we found that caspase 8 is activated
in a time-dependent manner, and either pharmacological
inhibition or knockdown of caspase 8 almost completely protects
cells from DHA-induced cell death (Fig. 2). Although pharma-
cological inhibition of caspase 9 also exerts a strong protection, its
protective effect is not as strong as caspase 8 inhibition. Because
caspase 9 is known to be activated following caspase 8 activation in
MCF-7 cells, which are Type II cells [34], it is postulated that
caspase 8 activation is an initiating event in DHA-induced
apoptotic cell death.
The mechanism by which DHA selectively activates caspase 8 is
still not understood at present. It is speculated that omega-3 FAs
may preferentially increase ROS accumulation in the plasma
membrane lipid rafts where the assembly of the death-inducing
signaling complex (DISC) and the subsequent activation of caspase
8 takes place [35]. The observation that the lipid-soluble a-
tocopherol is more potent and efficacious in protecting DHA-
induced apoptosis as compared to the water-soluble ascorbic acid
or N-acetylcysteine (NAC) provides partial support for the notion
that the production and accumulation of ROS in the lipid-rich
micro-environments may contribute importantly to caspase 8
activation and, subsequently, apoptosis induction in DHA-treated
cells. The proposed mechanism of DHA-induced apoptosis as
observed in cultured MCF-7 human breast cancer cells is depicted
in Fig. 7.
It is known that the membrane FA composition in cancer cells
can be modified either in culture or during growth in vivo
without disrupting the membrane integrity [36]. As shown in
Figure 6, the levels of DHA in plasma and tissues (including
mammary tissues and tumors) in animals fed a 5% fish oil diet
are increased significantly. The total plasma concentrations of
DHA and EPA in animals fed a diet supplemented with fish oil
are approximately 400 mMa n d8 0 0mM, respectively, although
it is not known what percentage of the detected omega-3 FAs is
i nt h ef r e e( u n c o n j u g a t e d )f o r m .Notably, while the concentra-
tions of linoleic acid (the source of arachidonic acid) in animals
fed a regular diet are highest in breast tissue compared to a few
other tissues examined in this study, feeding animals with a diet
supplemented with fish oil for 6 weeks completely alters the
composition of various fatty acidsi nb r e a s tt i s s u e ,w i t ham a r k e d
increase in EPA and DHA levels along with a drastic decrease in
linoleic acid levels. Since a strong suppression of tumor growth
is seen in animals fed a fish oil-supplemented diet while no
significant change of animal body weight (or other signs of
adverse effects) is observed, it is believed that effective
concentrations of omega-3 FAs likely are achievable in vivo
following oral ingestion of omega-3 FAs. Also, it is apparent that
the omega-3 FAs are essentially non-toxic in vivo at the effective
anticancer dose used.
Epidemiological studies have led to the suggestion that at least
one-third of the human cancers are associated with diet [37]. It
was estimated that an adult human could consume approximately
10–12 g fish oil per day without noticeable adverse effects [38].
Based on this information, the effective dose used in the present
preclinical study through feeding animals a 5% fish oil-
supplemented diet may also be achievable in humans through
increased dietary intake [39]. The results of our present study,
along with the data from recent studies by others suggest that
DHA may improve the outcomes of chemotherapy in breast
cancer patients via increased ROS formation [40,41], call for
additional studies to determine whether the use of dietary omega-3
FAs will have a similar suppressive effect on cancer growth in
breast cancer patients.
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